100901-97-1 Usage
Uses
Used in Pharmaceutical Research and Development:
(tert-butyloxycarbonyl)-L-phenylalanyl-L-histidyl-(3S,4S)-statyl-L-leucine hydrazide is used as a research tool for understanding enzyme inhibition and protein structure. Its unique properties allow it to be a valuable asset in the development of new pharmaceuticals and therapeutic agents.
Used in Enzyme Inhibition Studies:
In the field of biochemistry, (tert-butyloxycarbonyl)-L-phenylalanyl-L-histidyl-(3S,4S)-statyl-L-leucine hydrazide is used as an enzyme inhibitor, helping researchers to study the mechanisms of enzyme action and develop targeted therapies for various diseases.
Used in Drug Discovery:
(tert-butyloxycarbonyl)-L-phenylalanyl-L-histidyl-(3S,4S)-statyl-L-leucine hydrazide's potential as a therapeutic agent has been demonstrated in preclinical studies, making it a promising candidate for drug discovery and the development of novel treatments for medical conditions.
Used in Medicinal Chemistry:
(tert-butyloxycarbonyl)-L-phenylalanyl-L-histidyl-(3S,4S)-statyl-L-leucine hydrazide's unique structure and properties make it a valuable tool in medicinal chemistry, where it can be utilized to design and synthesize new drugs with improved efficacy and selectivity.
Check Digit Verification of cas no
The CAS Registry Mumber 100901-97-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,0,9,0 and 1 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 100901-97:
(8*1)+(7*0)+(6*0)+(5*9)+(4*0)+(3*1)+(2*9)+(1*7)=81
81 % 10 = 1
So 100901-97-1 is a valid CAS Registry Number.
100901-97-1Relevant academic research and scientific papers
Renin inhibitors. Statine-containing tetrapeptides with varied hydrophobic carboxy termini
Bock,DiPardo,Evans,Rittle,Boger,Poe,LaMont,Lynch,Ulm,Vlasuk,Greenlee,Veber
, p. 1853 - 1857 (2007/10/02)
A series of statine-containing tetrapeptides, systematically modified at the carboxy terminus with various hydrophobic aromatic groups, is described. These compounds were tested in vitro for their ability to inhibit porcine, human plasma, and purified hum
